CIBC Asset Administration Inc decreased its place in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 1.2% within the 2nd quarter, based on its most up-to-date submitting with the Securities and Change Fee. The fund owned 24,240 shares of the corporate’s inventory after promoting 285 shares in the course of the quarter. CIBC Asset Administration Inc’s holdings in IDEXX Laboratories have been price $11,810,000 as of its most up-to-date submitting with the Securities and Change Fee.
A number of different institutional buyers have additionally lately added to or decreased their stakes within the firm. Norges Financial institution acquired a brand new place in shares of IDEXX Laboratories in the course of the 4th quarter valued at about $512,190,000. Capital Analysis International Traders acquired a brand new place in shares of IDEXX Laboratories in the course of the 4th quarter valued at about $135,910,000. TD Asset Administration Inc elevated its stake in shares of IDEXX Laboratories by 178.8% in the course of the 4th quarter. TD Asset Administration Inc now owns 260,008 shares of the corporate’s inventory valued at $144,317,000 after buying an extra 166,751 shares over the last quarter. Point72 Asset Administration L.P. acquired a brand new place in shares of IDEXX Laboratories in the course of the 4th quarter valued at about $78,001,000. Lastly, Jupiter Asset Administration Ltd. acquired a brand new place in shares of IDEXX Laboratories in the course of the 1st quarter valued at about $55,425,000. Institutional buyers and hedge funds personal 87.84% of the corporate’s inventory.
Analysts Set New Worth Targets
A variety of analysis corporations have lately commented on IDXX. BTIG Analysis initiated protection on shares of IDEXX Laboratories in a analysis be aware on Thursday, July twenty fifth. They set a “purchase” score and a $580.00 value goal for the corporate. StockNews.com lower IDEXX Laboratories from a “purchase” score to a “maintain” score in a report on Wednesday, July tenth. Piper Sandler decreased their goal value on IDEXX Laboratories from $600.00 to $520.00 and set a “impartial” score for the corporate in a report on Wednesday, August 14th. Morgan Stanley decreased their goal value on IDEXX Laboratories from $620.00 to $596.00 and set an “chubby” score for the corporate in a report on Tuesday, Could 14th. Lastly, Stifel Nicolaus decreased their goal value on IDEXX Laboratories from $520.00 to $510.00 and set a “maintain” score for the corporate in a report on Monday, June twenty fourth. Three analysts have rated the inventory with a maintain score and 7 have issued a purchase score to the corporate. Primarily based on knowledge from MarketBeat.com, the corporate at the moment has a mean score of “Average Purchase” and a mean value goal of $582.25.
Verify Out Our Newest Report on IDEXX Laboratories
IDEXX Laboratories Inventory Down 2.6 %
NASDAQ IDXX opened at $469.01 on Wednesday. The inventory has a market cap of $38.73 billion, a PE ratio of 45.40, a P/E/G ratio of 4.10 and a beta of 1.32. The corporate has a fast ratio of 1.03, a present ratio of 1.37 and a debt-to-equity ratio of 0.33. The enterprise has a 50 day shifting common value of $480.93 and a two-hundred day shifting common value of $505.29. IDEXX Laboratories, Inc. has a fifty-two week low of $372.50 and a fifty-two week excessive of $583.39.
IDEXX Laboratories (NASDAQ:IDXX – Get Free Report) final launched its earnings outcomes on Tuesday, August sixth. The corporate reported $2.44 EPS for the quarter, lacking the consensus estimate of $2.88 by ($0.44). The enterprise had income of $1 billion for the quarter, in comparison with analysts’ expectations of $1.01 billion. IDEXX Laboratories had a web margin of twenty-two.34% and a return on fairness of 57.03%. The enterprise’s quarterly income was up 6.4% in comparison with the identical quarter final yr. Throughout the identical quarter final yr, the corporate posted $2.67 earnings per share. As a bunch, sell-side analysts predict that IDEXX Laboratories, Inc. will publish 10.45 EPS for the present fiscal yr.
IDEXX Laboratories Firm Profile
IDEXX Laboratories, Inc develops, manufactures, and distributes merchandise primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The corporate operates by means of three segments: Companion Animal Group; Water High quality Merchandise; and Livestock, Poultry and Dairy.
See Additionally
Need to see what different hedge funds are holding IDXX? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report).
Obtain Information & Scores for IDEXX Laboratories Day by day – Enter your e-mail handle under to obtain a concise day by day abstract of the most recent information and analysts’ scores for IDEXX Laboratories and associated corporations with MarketBeat.com’s FREE day by day e-mail publication.
